In order to achieve the vision of personalised cancer treatment, clinical pathology must develop better tools to be able to “predict in the tissue”, i.e., identify biological properties, known as biomarkers, in individual tumours, which are of significance to disease progression (prognosis) and the effect of different treatments (prediction). The concept means that, for every cancer patient, tissue samples are collected and organized from diagnostic biopsy, primary tumour and all metastases in a handy ‘single patient tissue chip “. The aim is to improve the accuracy of the biomarker analysis that needs to be made and therefore the choice of treatment.
Menu